维升药业-B盘中涨超6% 公司预计隆培促生长素于下半年在国内获批上市

智通财经
03 Jun

维升药业-b(02561)盘中涨超6%,截至发稿,涨5.95%,报47.2港元,成交额131.9万港元。中信证券发布研报指出,公司为内分泌领域的创新药企,目前拥有三款产品,由ascendis pharma引入;Ascendis Pharma为公司的深度合作伙伴,近期在美股市值为100亿美元左右,体现了市场对其核心技术平台的高度认可。该行续指,根据公司招股书,公司研发进展最快的是隆培促生长素(长效...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10